186 filings
Page 2 of 10
6-K
ahehqsi6
30 Nov 22
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development
7:09am
6-K
sjd4 280jt
28 Oct 22
Current report (foreign)
8:00am
6-K
rufdlf2jz6243 k42fa
26 Sep 22
AC Immune Partner LMI Progresses Tau PET Tracer PI-2620 into Late-stage Development in Alzheimer’s Disease
9:07am
6-K
1alh4oa
2 Aug 22
Detailed data from the phase II Crenezumab Alzheimer’s Prevention Initiative Study in Autosomal Dominant Alzheimer’s Disease Presented at AAIC
11:12am
6-K
fad3y9s
28 Jul 22
Current report (foreign)
7:36am
6-K
0uca9w807vfki6a
24 Jun 22
Current report (foreign)
5:29pm
6-K
rfv5e
16 Jun 22
AC Immune provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease
7:38am
6-K
wjyl79c5lmo7oztf
25 May 22
Notice of the Annual General Meeting 2022 To the Shareholders of AC Immune SA
4:29pm
424B5
pas3ho5to432k27zv
19 May 22
Prospectus supplement for primary offering
7:22am
6-K
4m8g995fmlvs
28 Apr 22
Current report (foreign)
7:37am
6-K
22syw4u4
8 Apr 22
AC Immune Reports Changes to Senior Management
7:36am
6-K
xjp0mivyx8xzoas3etdl
22 Mar 22
AC Immune Reports Full Year 2021 Financial Results and Provides Corporate Update
7:03am
6-K
pws5udbsdtu
16 Mar 22
AC Immune Reports First Live Images of Alpha-Synuclein in Human Brain with New PET Tracer for Neurodegenerative Disease at AD/PDTM Conference
7:51am
6-K
1lxh3hw3 bcsuiddp
12 Nov 21
AC Immune Announces Interim Phase 1b/2a Data Showing that its ACI-35.030 Anti-pTau Alzheimer’s Vaccine Generates a Potent Immune Response
9:27am
6-K
g339mvp 4hynm
8 Nov 21
Current report (foreign)
7:27am
6-K
6xlatsi2v
29 Oct 21
AC Immune Holds its Extraordinary General Meeting and Appoints Monica Shaw, M.D., and Prof. Monika Bütler, Dr. oec., to its Board of Directors
4:35pm
6-K
tatv7zydqtqsq3vytmi
15 Oct 21
Current report (foreign)
7:25am
6-K
d47wys86 lm
7 Oct 21
Notice of the Extraordinary General Meeting (EGM) of 29 October 2021 To the Shareholders of AC Immune SA 1
7:27am
6-K
eem6n4t
31 Aug 21
AC Immune Announces First Positive Cognitive Results for a Tau-Targeting Monoclonal Antibody in Alzheimer’s Disease
8:34am